Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

NCT07226258 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis Knee Pain

Interventions

DRUG: SL1002
DRUG: Normal Saline

Sponsor

Saol Therapeutics Inc